PeerView Gastroenterology CME/CNE/CPE Video Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇯🇵JP · Science#1431K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
300 to 3K🎙 Daily cadence·96 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
1K to 10K🇯🇵100% - Active Followers
Loyal subscribers who consistently listen
300 to 3K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHost
Recent guests
Recent episodes
Yelena Y. Janjigian, MD* - Scaling New Heights in Gastric/GEJ Cancer: Aligning the Evidence on Targeted and Immunotherapeutic Approaches Across the Disease Continuum
Jul 20, 2026
1h 31m 14s
Scott Kopetz, MD, PhD, FACP - Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment
Jul 8, 2026
1h 33m 32s
Anita Afzali, MD, MPH, MHCM, FACG, AGAF / Jessica R. Allegretti, MD, MPH, FACG, AGAF / Millie D. Long, MD, MPH - At the Crossroads of Inflammation and Fibrosis in Inflammatory Bowel Disease: The Promise of TL1A Inhibition
May 29, 2026
1h 10m 58s
Eileen M. O'Reilly, MD, FASCO - Redefining Precision Oncology in Pancreatic Cancer: Translating Emerging KRAS-Targeted Strategies into Effective Clinical Management
May 12, 2026
51m 31s
Yelena Y. Janjigian, MD*, Marion Liu, MD - Unifying Surgical-Oncology Expertise in Resectable Gastric/GEJ Malignancies: Leveraging the Evidence on Perioperative Immunotherapy Platforms to Deliver Personalized Care
Apr 3, 2026
1h 04m 29s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/20/26 | Gastric CancerGEJ Cancer+4 | Yelena Y. Janjigian, MD | PVI, PeerView Institute for Medical EducationHope For Stomach Cancer+3 | — | gastric cancerGEJ cancer+5 | AstraZeneca | 1h 31m 14s | ||
| 7/8/26 | Colorectal CancerImmunotherapy+3 | Scott Kopetz, MD, PhD, FACP | PVI, PeerView Institute for Medical EducationColorectal Cancer Alliance | — | CMECRC Treatment+3 | Bristol Myers Squibb | 1h 33m 32s | ||
| 5/29/26 | InflammationFibrosis+4 | Anita Afzali, MD, MPH, MHCM, FACG, AGAFJessica R. Allegretti, MD, MPH, FACG, AGAF+1 | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Inflammatory Bowel DiseaseTL1A Inhibition+5 | Merck & Co., Inc. | 1h 10m 58s | ||
| 5/12/26 | Precision OncologyPancreatic Cancer+3 | Eileen M. O'Reilly, MD, FASCO | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | pancreatic cancerprecision oncology+3 | Revolution Medicines | 51m 31s | ||
| 4/3/26 | surgical oncologygastric malignancies+3 | Yelena Y. Janjigian, MDMarion Liu, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | gastric cancerGEJ malignancies+4 | AstraZeneca | 1h 04m 29s | ||
| 4/3/26 | biliary cancerFGFR-targeted platforms+3 | Tanios Bekaii-Saab, MD, FACP, FASCO | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | biliary cancerFGFR-targeted therapy+3 | Incyte Corporation | 34m 35s | ||
| 4/1/26 | Desmoid TumorsGamma Secretase Inhibitors+3 | Mrinal Gounder, MD | PVI, PeerView Institute for Medical EducationSociety of Surgical Oncology+3 | — | Desmoid TumorsGamma Secretase Inhibitors+3 | SpringWorks Therapeutics, Inc. | 1h 00m 26s | ||
| 3/4/26 | Gastric CancerImmunotherapy+3 | Samuel Cytryn, MDDaniela Molena, MD+1 | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | gastric cancerGEJ cancer+3 | AstraZeneca | 1h 00m 03s | ||
| 2/12/26 | HCCsystemic treatment+3 | Prof. Dr. Peter R. Galle | PVI, PeerView Institute for Medical EducationBlue Faery: The Adrienne Wilson Liver Cancer Association | — | HCCsystemic treatment+3 | AstraZeneca | 1h 32m 44s | ||
| 2/4/26 | targeted therapyextrapulmonary neuroendocrine carcinomas+3 | Jaume Capdevila, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | neuroendocrine carcinomastargeted therapy+3 | Boehringer Ingelheim Pharmaceuticals, Inc. | 32m 56s | ||
| 1/9/26 | metastatic colorectal cancerlung cancer+4 | Ibiayi Dagogo-Jack, MD, FASCOVan Karlyle Morris, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | metastatic cancercolorectal cancer+5 | Pfizer | 51m 25s | ||
| 12/29/25 | gastric cancer managementsystemic therapies+3 | Geoffrey Ku, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | gastric cancersystemic therapies+5 | AstraZeneca | 46m 40s |
Showing 12 of 12
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for PeerView Gastroenterology CME/CNE/CPE Video Podcast
Peaked at #143 in Japan, currently #143 in Japan.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Japan | — | #143 | #143 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.